TORONTO--(BUSINESS WIRE)--StemCellPatents.com supports today’s announcement by the United States Patent and Trademark Office that three patents covering embryonic stem cell composition of matter will be re-examined in light of existing prior art. We support this announcement because the re-examination process will initiate a constructive public dialogue and will add to the public's understanding of the merits by which patents in such a complex field are granted.
